Skip to main content

Company

Express Scripts

74 published works

  1. The Healthcare Investor

    Healthcare & Life Sciences Private Equity Deal Tracker: Express Scripts to Acquire PE-Backed eviCore for $3.6 Billion

    By Geoff Cockrell

    Express Scripts will acquire eviCore healthcare for $3.6 billion from investors including General Atlantic, TA Associates and Ridgemont Equity Partners, according to a news release. eviCore, headquartered in Bluffton, South…

  2. Pharmacy & Healthcare Legal Blog

    64 drugs will no longer be covered by Express Scripts in 2018

    By Natalia Mazina

    Express Scripts has announced further cuts on a number of reimbursed drugs to make its formularies more clinically appropriate and cost effective. Currently, Express Scripts covers approximately 3,791 drugs and…

  3. Delaware Corporate & Commercial Litigation Blog

    Section 220 Decision Imposed Conditions on Production of Corporate Documents

    By Francis Pileggi

    A multitude of decisions and commentary about DGCL Section 220 have filled these pages over the last 12 years.  This recent Court of Chancery decision is an example of a…

  4. Pharmacy & Healthcare Legal Blog

    A case against major PBMs by compounding pharmacies continues…

    By Natalia Mazina

    A little background on the case: In 2015, three compounding pharmacies brought a case against four largest PBMs—Express Scripts, CVS Health Corporation, OptumRx, Inc., and Prime Therapeutics, LLC—under the Employee Retirement…

  5. Pharmacy & Healthcare Legal Blog

    PBM Trends, 2016-2017 and beyond

    By Natalia Mazina

    Happy 2017 to all of you working with PBMs! You made it through a tough 2016. By that I mean: Increased PBM transparency Constant pressure on lowering cost Shorter-term contracts…

  6. Healthcare Law Blog

    Day Two Notes – JP Morgan Healthcare Conference, San Francisco

    By Eric Klein

    It was another interesting day at JP Morgan, the healthcare conference that never disappoints. Surprising declarations of war and peace, partnering that really works and strong growth stories all were…

  7. FCA Update

    Recent Appellate Decisions Underscore Importance of Public Disclosure Bar, But Outcomes Are Highly Dependent on the Facts

    By McDermott Will & Emery

    Two Circuit Courts of Appeals recently came out on opposite ends of the False Claim Act’s (FCA’s) public disclosure bar.  On February 19, 2015, the United States Court of Appeals…

  8. Drug & Device Law

    The Flip Side of Pharmacy Liability

    By Michelle Yeary

    On Friday, we posted about a Florida court that allowed negligence claims against a pharmacy that did nothing more than fill prescriptions as they were written (Oleckna).  As you can imagine, we…

  9. Health Law Update

    Pharmacy Benefit Manager Faces Lawsuit by Compounding Pharmacies

    By Lee H. Rosebush, Nita Garg

    In response to a decision to deny coverage of approximately 1,000 active ingredients that are widely used by compounding pharmacies to create topical treatments, three compounding pharmacies have filed a…

  10. D.C. Medical Malpractice Blog

    Pharmaceutical Compounds: Investigating and Regulating Their Use (Part 2)

    By Regan Zambri & Long

    In our last post, we discussed how pharmaceutical companies have begun to profit from the proliferation of compound drugs, as reported by the New York Times. Today, we will examine…